changing from tirzepatide to retatrutide How Switch To Tirzepatide vs. Retatrutide: Key Differences

Adults with overweight or obesity taking the once-weekly GIP/GLP-1 receptor agonist tirzepatide achieved a mean weight loss of at least 16% at 72 weeks, according to topline results from the SURMOUNT-1 clinical trial

Rotating injection sites is important for all three medications

To start saving, you can get your free BuzzRx prescription discount card HERE or download the free mobile app from the App Store

Put those two facts together, and it should come as no surprise that a new class of drugs to help people lose weight including Ozempic, Wegovy and similar medications has soared in popularity

This is a significant practical advantage

"People should always work their physician to determine what works for them based on their history," Novo Nordisk says in a statement when asked about this issue